Cargando…
Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels
Despite potently inhibiting the nociceptive voltage-gated sodium (Na(v)) channel, Na(v)1.7, µ-theraphotoxin Pn3a is antinociceptive only upon co-administration with sub-therapeutic opioid agonists, or by itself at doses >3,000-fold greater than its Na(v)1.7 IC (50) by a yet undefined mechanism. N...
Autores principales: | McArthur, Jeffrey R., Munasinghe, Nehan R., Finol-Urdaneta, Rocio K., Adams, David J., Christie, Macdonald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875911/ https://www.ncbi.nlm.nih.gov/pubmed/33584315 http://dx.doi.org/10.3389/fphar.2020.633679 |
Ejemplares similares
-
Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition
por: Munasinghe, Nehan R., et al.
Publicado: (2015) -
µ-Theraphotoxin Pn3a inhibition of Ca(V)3.3 channels reveals a novel isoform-selective drug binding site
por: McArthur, Jeffrey R, et al.
Publicado: (2022) -
Pharmacological characterisation of the highly Na(V)1.7 selective spider venom peptide Pn3a
por: Deuis, Jennifer R., et al.
Publicado: (2017) -
Corrigendum: Pharmacological characterisation of the highly Na(V)1.7 selective spider venom peptide Pn3a
por: Deuis, Jennifer R., et al.
Publicado: (2017) -
Open-state stabilization in Kv channels: Voltage-sensor relaxation and pore propping by a bound ion
por: French, Robert J., et al.
Publicado: (2012)